This episode details how psoriatic arthritis and the spondyloarthropathies came to be recognized as a distinct clinical entity after decades of nerdy arguing.

Brought to you by Actemra.

• Intro :10
• Shout out to Cleveland Clinic Biologic Therapies Summit :30
• In this episode 1:29
• A 30,000-foot view 2:34
• When did PsA separate from rheumatoid arthritis? 3:34
• Mary Stults Sherman 7:11
• Verna Wright and Dr. John Moll put PsA on the map 9:09
• Recognizing PsA as a disease 15:20
• An anecdote about Wright 16:18
• Putting the SpA puzzle pieces together 18:19
• The severity of disease 19:08
• Episode wrap-up 20:46

Disclosures: Brown reports no relevant financial disclosures.

We’d love to hear from you! Send your comments/questions to Dr. Brown at [email protected]. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum

References:

Ankylosing Spondylitis, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1980.

Espinoza LR, Helliwell P. Clinical Rheumatology. 2014;33:1335-1336.

Gladman DD, et al. Q J Med. 1987;62:127-141.

Kane D, et al. Rheumatology. 2003;42:1460-1468.

Moll JMH. Reumatismo. 2007;59 Suppl 1:13-18.

Moll JM, Wright V. Semin Arthritis Rheum. 1973;3:55-78.

Seronegative polyarthritis, North-Holland Pub. Co., New York, Amsterdam, 1976.

Sound effects obtained from https://www.zapsplat.com

Wright V. Am J Med. 1959;27:454-462.

Wright V. Ann Rheum Dis. 1956;15:348-356.

Wright V. BMJ. 1994;309:1739-1740.